Literature DB >> 31784120

Amniotic membrane, clinical applications and tissue engineering. Review of its ophthalmic use.

J Lacorzana1.   

Abstract

The use of amniotic membrane in ophthalmology has been increasing in recent years due to its multiple biological and tectonic properties, improvement in the process of obtaining, ease of use, and advancement in tissue engineering. The amniotic membrane has become one of the main adjuvant treatments, in ophthalmic surgery as well as in other medical-surgical specialties. The development of tissue engineering has allowed it to be used, not only in its classic form, but also by the use of drops and other presentations. The different steps prior to its use (preparation and conservation), the different surgical techniques, and their main clinical applications are described throughout the article.
Copyright © 2019 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Keywords:  Amniotic membrane; Cornea; Córnea; Ingeniería tisular; Membrana amniótica; Ocular surface; Superficie ocular; Tissue engineering

Mesh:

Substances:

Year:  2019        PMID: 31784120     DOI: 10.1016/j.oftal.2019.09.010

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol (Engl Ed)        ISSN: 2173-5794


  3 in total

1.  Effect of Amniotic Membrane/Collagen-Based Scaffolds on the Chondrogenic Differentiation of Adipose-Derived Stem Cells and Cartilage Repair.

Authors:  Le Cao; Yuling Tong; Xiao Wang; Qiang Zhang; Yiying Qi; Chenhe Zhou; Xinning Yu; Yongping Wu; Xudong Miao
Journal:  Front Cell Dev Biol       Date:  2021-11-25

2.  Standardized reporting of amnion and amnion/chorion allograft data for wound care.

Authors:  Taylor J Sabol; Grace S Tran; Jason Matuszewski; Wendy W Weston
Journal:  Health Sci Rep       Date:  2022-08-23

3.  Biomechanical Modulation Therapy-A Stem Cell Therapy Without Stem Cells for the Treatment of Severe Ocular Burns.

Authors:  Ricardo M Gouveia; Che J Connon
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.